Evaluation (ID: i712a) Survey

Question Title

* 1. Following participation in this activity, please select which of the following items you include or will include in patient education plans in your current practice.

Basic facts about asthma

Definitions of well-controlled asthma

Roles of medications

Inhaler technique

What to do in the event of increasing symptoms

Measures to limit exposure to triggers

Question Title

* 2. After participating in this activity, I have improved knowledge of clinical data supporting use of new and emerging therapies for severe asthma.

Strongly agree

Agree

Neutral

Disagree

Strongly disagree

Question Title

* 3. What additional information would be helpful in improving knowledge of data supporting therapies for individualized disease management?

Question Title

* 4. As a result of participating in this activity, will you change components of your communication with patients with severe asthma? If so, please describe changes.

Question Title

* 5. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information that I can apply to my area of practice.

I need more information before I change my practice behavior.

This activity will not change my practice, as my current practice is consistent with the information presented.

This activity will not change my practice, as I do not agree with the information presented.

Question Title

* 6. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

Question Title

* 7. As a result of your participation in this activity, what strategies/changes do you plan to implement in your practice?

Question Title

* 8. What barriers do you see to making changes in your practice?

Question Title

* 9. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 10. After participating in today’s activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Describe clinical criteria for severe asthma and outline an approach to assessing symptom control and disease burden	Describe clinical criteria for severe asthma and outline an approach to assessing symptom control and disease burden Strongly agree	Describe clinical criteria for severe asthma and outline an approach to assessing symptom control and disease burden Agree	Describe clinical criteria for severe asthma and outline an approach to assessing symptom control and disease burden Neutral	Describe clinical criteria for severe asthma and outline an approach to assessing symptom control and disease burden Disagree	Describe clinical criteria for severe asthma and outline an approach to assessing symptom control and disease burden Strongly disagree
Identify known phenotypes of severe asthma	Identify known phenotypes of severe asthma Strongly agree	Identify known phenotypes of severe asthma Agree	Identify known phenotypes of severe asthma Neutral	Identify known phenotypes of severe asthma Disagree	Identify known phenotypes of severe asthma Strongly disagree
Develop an approach to the treatment of severe asthma that is personalized to the individual patient and describe the most recent clinical data on new and emerging therapies for severe asthma	Develop an approach to the treatment of severe asthma that is personalized to the individual patient and describe the most recent clinical data on new and emerging therapies for severe asthma Strongly agree	Develop an approach to the treatment of severe asthma that is personalized to the individual patient and describe the most recent clinical data on new and emerging therapies for severe asthma Agree	Develop an approach to the treatment of severe asthma that is personalized to the individual patient and describe the most recent clinical data on new and emerging therapies for severe asthma Neutral	Develop an approach to the treatment of severe asthma that is personalized to the individual patient and describe the most recent clinical data on new and emerging therapies for severe asthma Disagree	Develop an approach to the treatment of severe asthma that is personalized to the individual patient and describe the most recent clinical data on new and emerging therapies for severe asthma Strongly disagree
Identify strategies for improving communication to promote collaborative decision-making and the ability to self-manage among patients with severe asthma	Identify strategies for improving communication to promote collaborative decision-making and the ability to self-manage among patients with severe asthma Strongly agree	Identify strategies for improving communication to promote collaborative decision-making and the ability to self-manage among patients with severe asthma Agree	Identify strategies for improving communication to promote collaborative decision-making and the ability to self-manage among patients with severe asthma Neutral	Identify strategies for improving communication to promote collaborative decision-making and the ability to self-manage among patients with severe asthma Disagree	Identify strategies for improving communication to promote collaborative decision-making and the ability to self-manage among patients with severe asthma Strongly disagree

Question Title

* 11. William W. Busse, MD, effectively

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 12. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 13. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 14. How would you rate the format of this activity?

Excellent

Average

Below average

Poor

Question Title

* 15. Would you be willing to participate in a postactivity follow-up survey?

Yes